肝水解肽

Records for this ingredient, by country (identity only).

ATC V02DD · 1 markets · 21 records

肝水解肽 1 markets · 21 records Forms
Filters
MarketCN 21

CN 21 records · 5 shown of 5 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 20 mg/2 mLinjectionManufacturer: 吉林敖东洮南药业股份有限公司Manufacturer: 吉林敖东药业集团延吉股份有限公司、Manufacturer: 白求恩医科大学制药厂、Manufacturer: 通化惠康生物制药有限公司、Manufacturer: 长春普华制药股份有限公司、Manufacturer: 长春精优药业股份有限公司
  • 100 mg/10 mLinjectionManufacturer: 吉林敖东药业集团延吉股份有限公司 ×6Manufacturer: 长春普华制药股份有限公司、Manufacturer: 长春白求恩制药有限公司
  • 50 mg/5 mLinjectionManufacturer: 吉林敖东药业集团延吉股份有限公司 ×6Manufacturer: 长春普华制药股份有限公司、Manufacturer: 长春白求恩制药有限公司
  • 50 mg per mL / per unit basis not statedinjectionManufacturer: 湖南五洲通药业股份有限公司 ×4
  • 20 mg per mL / per unit basis not statedinjectionManufacturer: 湖南五洲通药业股份有限公司 ×4

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.